These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

58 related articles for article (PubMed ID: 24870139)

  • 1. Approaches for classifying DNA variants found by Sanger sequencing in a medical genetics laboratory.
    Cheong PL; Caramins M
    Methods Mol Biol; 2014; 1168():227-50. PubMed ID: 24870139
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Integrating massively parallel sequencing into diagnostic workflows and managing the annotation and clinical interpretation challenge.
    Kassahn KS; Scott HS; Caramins MC
    Hum Mutat; 2014 Apr; 35(4):413-23. PubMed ID: 24510514
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Annotation of Sequence Variants in Cancer Samples: Processes and Pitfalls for Routine Assays in the Clinical Laboratory.
    Lee LA; Arvai KJ; Jones D
    J Mol Diagn; 2015 Jul; 17(4):339-51. PubMed ID: 25977238
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Massively parallel sequencing: the next big thing in genetic medicine.
    Tucker T; Marra M; Friedman JM
    Am J Hum Genet; 2009 Aug; 85(2):142-54. PubMed ID: 19679224
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Clinical genomics information management software linking cancer genome sequence and clinical decisions.
    Watt S; Jiao W; Brown AM; Petrocelli T; Tran B; Zhang T; McPherson JD; Kamel-Reid S; Bedard PL; Onetto N; Hudson TJ; Dancey J; Siu LL; Stein L; Ferretti V
    Genomics; 2013 Sep; 102(3):140-7. PubMed ID: 23603536
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Clinical classification of BRCA1 and BRCA2 DNA sequence variants: the value of cytokeratin profiles and evolutionary analysis--a report from the kConFab Investigators.
    Spurdle AB; Lakhani SR; Healey S; Parry S; Da Silva LM; Brinkworth R; Hopper JL; Brown MA; Babikyan D; Chenevix-Trench G; Tavtigian SV; Goldgar DE;
    J Clin Oncol; 2008 Apr; 26(10):1657-63. PubMed ID: 18375895
    [TBL] [Abstract][Full Text] [Related]  

  • 7. SeqReporter: automating next-generation sequencing result interpretation and reporting workflow in a clinical laboratory.
    Roy S; Durso MB; Wald A; Nikiforov YE; Nikiforova MN
    J Mol Diagn; 2014 Jan; 16(1):11-22. PubMed ID: 24220144
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Clinical application of amplicon-based next-generation sequencing in cancer.
    Chang F; Li MM
    Cancer Genet; 2013 Dec; 206(12):413-9. PubMed ID: 24332266
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Next-generation sequencing and its applications in molecular diagnostics.
    Su Z; Ning B; Fang H; Hong H; Perkins R; Tong W; Shi L
    Expert Rev Mol Diagn; 2011 Apr; 11(3):333-43. PubMed ID: 21463242
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Exome sequencing analysis: a guide to disease variant detection.
    Isakov O; Perrone M; Shomron N
    Methods Mol Biol; 2013; 1038():137-58. PubMed ID: 23872973
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Performance evaluation of the next-generation sequencing approach for molecular diagnosis of hereditary hearing loss.
    Sivakumaran TA; Husami A; Kissell D; Zhang W; Keddache M; Black AP; Tinkle BT; Greinwald JH; Zhang K
    Otolaryngol Head Neck Surg; 2013 Jun; 148(6):1007-16. PubMed ID: 23525850
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Medical genomics: The intricate path from genetic variant identification to clinical interpretation.
    Quintáns B; Ordóñez-Ugalde A; Cacheiro P; Carracedo A; Sobrido MJ
    Appl Transl Genom; 2014 Sep; 3(3):60-7. PubMed ID: 27284505
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Key principles and clinical applications of "next-generation" DNA sequencing.
    Rizzo JM; Buck MJ
    Cancer Prev Res (Phila); 2012 Jul; 5(7):887-900. PubMed ID: 22617168
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effective variant detection by targeted deep sequencing of DNA pools: an example from Parkinson's disease.
    Pihlstrøm L; Rengmark A; Bjørnarå KA; Toft M
    Ann Hum Genet; 2014 May; 78(3):243-52. PubMed ID: 24660942
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Impacts of massively parallel sequencing for genetic diagnosis of neuromuscular disorders.
    Vasli N; Laporte J
    Acta Neuropathol; 2013 Feb; 125(2):173-85. PubMed ID: 23224362
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Design of targeted, capture-based, next generation sequencing tests for precision cancer therapy.
    Hagemann IS; Cottrell CE; Lockwood CM
    Cancer Genet; 2013 Dec; 206(12):420-31. PubMed ID: 24388712
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Applications.
    Josko D
    Clin Lab Sci; 2014; 27(3):179-84. PubMed ID: 25219076
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Evaluating DNA sequence variants of unknown biological significance.
    Grist SA; Dubowsky A; Suthers G
    Methods Mol Med; 2008; 141():199-217. PubMed ID: 18453091
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Preparation of genome-wide DNA fragment libraries using bisulfite in polyacrylamide gel electrophoresis slices with formamide denaturation and quality control for massively parallel sequencing by oligonucleotide ligation and detection.
    Ranade SS; Chung CB; Zon G; Boyd VL
    Anal Biochem; 2009 Jul; 390(2):126-35. PubMed ID: 19379703
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The SNPs in the human genetic blueprint era.
    Giampaoli S; Chillemi G; Valeriani F; Lazzaro D; Borro M; Gentile G; Simmaco M; Zanni G; Berti A; Romano Spica V
    N Biotechnol; 2013 Jun; 30(5):475-84. PubMed ID: 23183540
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 3.